Article 28 of the ATMP Regulation also empowers Member States to permit the manufacturing and use of certain non- routine produced advanced therapies that have not been authorised by the Commission under certain conditions (so-called “Hospital Exemption”) outside the scope of the Medicinal Product Directive 2001/23.
View this resource Bookmark this resource
Magisterial hospital preparations – hospital exemptions
Published by IRDiRC
Regulatory AffairsEarly Access SupportAdvanced TherapyHospital ExemptionATMPs